Vimarsana
Biggest News Aggregation in the World

Page 6 - William Collier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from William Collier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In William Collier Today - Breaking & Trending Today

Man arrested for open murder, woman dies in attack at Virginia City Highlands residence - Vimarsana News

Man arrested for open murder, woman dies in attack at Virginia City Highlands residence

A man is being held on a charge of open murder after a woman died from injuries sustained in an attack that happened Sunday at a Virginia City Highland's home, according to the Storey County Sheriff's Office.

Arbutus Announces Pipeline Updates and Dosing of the First Subject in the Phase 1a/1b Clinical Trial with AB-101; Cash Runway Extended - Vimarsana News

Arbutus Announces Pipeline Updates and Dosing of the First Subject in the Phase 1a/1b Clinical Trial with AB-101; Cash Runway Extended

11.09.2023 - Progressing development of hepatitis B virus (HBV) compounds imdusiran (AB-729) and AB-101, an oral PD-L1 inhibitor Discontinuing all coronavirus and oral RNA destabilizer programs, including AB-343 and AB-161 Extending cash runway through Q3 2025 ... Seite 1

Richard Mille Cup: a classic yacht revival - Vimarsana News

Richard Mille Cup: a classic yacht revival

A new regatta for classic yachts, the Richard Mille Cup, aims to recreate the famous era of the British ‘Big Class’. Dan Houston joins the Richard Mille Cup

Arbutus Reports Second Quarter 2023 Financial Results and Corporate Update - Vimarsana News

Arbutus Reports Second Quarter 2023 Financial Results and Corporate Update

03.08.2023 - Regulatory approval received in New Zealand to advance AB-101, our oral PD-L1 inhibitor, into a Phase 1 clinical trial with dosing to begin this quarter AB-729 (imdusiran), in combination with pegylated interferon alfa-2a, in a Phase ...

Arbutus Appoints Melissa V. Rewolinski, PhD to its Board of Directors - Vimarsana News

Arbutus Appoints Melissa V. Rewolinski, PhD to its Board of Directors

WARMINSTER, Pa., July 12, 2023 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target...